DOI: 10.1128/AAC.00585-16
Article Information
PubMed
Published By
History
- Received March 14, 2016
- Returned for modification April 24, 2016
- Accepted June 22, 2016
- Published online September 23, 2016.
Copyright & Usage
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (July 25, 2016).
- You are viewing the most recent version of this article.
Author Information
- aUniversity of Colorado Denver, School of Medicine, Department of Anesthesiology, Aurora, Colorado, USA
- bDepartment of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA
- cUniversity of Colorado Denver, School of Medicine, Department of Surgery, Surgical Weight Loss Center, Aurora, Colorado, USA
- Address correspondence to Pierre Moine, pierre.moine{at}ucdenver.edu.
P.M., S.W.M., and D.N.F. contributed equally to this article.
Citation Moine P, Mueller SW, Schoen JA, Rothchild KB, Fish DN. 2016. Pharmacokinetic and pharmacodynamic evaluation of a weight-based dosing regimen of cefoxitin for perioperative surgical prophylaxis in obese and morbidly obese patients. Antimicrob Agents Chemother 60:5885–5893. doi:10.1128/AAC.00585-16.
